Has Rahul Mehan, MD received payments from drug or device companies?

Yes. Drug and device makers reported $276,583 in general payments to Rahul Mehan, MD across 682 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Rahul Mehan, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Rahul Mehan, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Rahul Mehan, MD

Urology · Mesa, AZNPI 1770740367

Payments from drug & device makers

$276,583in general payments, 2019–2025

Across 682 payments — averaging $405.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Procept Biorobotics Corporation$154K
Boston Scientific$70K
Olympus America Inc.$16K
Astellas Pharma US Inc$9K
Olympus Corporation Of The Americas$8K
Endo Pharmaceuticals Inc.$5K
plus $14K from 54 others

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Procept Biorobotics Corporation	142	$154,285
Boston Scientific	138	$70,222
Olympus America Inc.	36	$15,793
Astellas Pharma US Inc	32	$9,291
Olympus Corporation Of The Americas	4	$7,968
Endo Pharmaceuticals Inc.	16	$5,208
Marius Pharmaceuticals, Inc	1	$3,750
Neotract Inc.	16	$1,436
Coloplast	41	$1,340
Medtronic	15	$887
Angiodynamics, Inc.	13	$722
AbbVie(2 entities)	28	$440
Calyxo, Inc.	5	$320
Dendreon Pharmaceuticals LLC	12	$317
Sumitomo Pharma America, Inc.	16	$309
Pfizer	14	$258
Urogen Pharma, Inc.	13	$251
180 Medical, Inc.	8	$244
Progenics Pharmaceuticals, Inc.	8	$206
Endo USA, Inc.	8	$194
Kowa Pharmaceuticals America, Inc.	10	$183
Ambu Inc.	7	$173
Histosonics, Inc.	2	$170
EDAP Technomed Inc	1	$168
Teleflex LLC	6	$156
Intuitive Surgical	4	$152
Conmed Corporation	1	$148
Verity Pharmaceuticals Inc.	6	$139
Laborie Medical Technologies Corp.	4	$132
Myriad Genetic Laboratories, Inc.	6	$122
Tolmar, Inc.	5	$121
Axonics, Inc.	5	$117
Accord Healthcare, Inc.	6	$109
Blue Earth Diagnostics	5	$99
Myovant Sciences Inc.	5	$97
Ferring Pharmaceuticals Inc.	4	$89
Hollister Incorporated	3	$81
Koelis Inc.	1	$81
Palette Life Sciences, Inc.	1	$70
Johnson & Johnson(2 entities)	3	$70
Merck	4	$61
Bluewind Medical	1	$58
Profound Medical Corp.	1	$50
KARL Storz Endoscopy-america	1	$48
C. R. Bard, Inc. & Subsidiaries	3	$47
Immunitybio, Inc.	2	$46
Cook Medical LLC	2	$34
Smith+Nephew	1	$32
Convatec Inc.	2	$29
E.r. Squibb & Sons, L.L.C.	1	$27
BD	1	$25
Urovant Sciences Inc	1	$25
Bioprotect Medical, Inc.	1	$22
Photocure Inc	1	$20
Mimedx Group, Inc.	1	$20
Clinical Laserthermia Systems Americas Inc.	1	$19
Healthtronics Stone Solutions, LLC	1	$18
Avadel Specialty Pharmaceuticals, LLC	1	$16
Vertex	1	$16
Covidien LP	1	$15

How this compares

$276,583 in reported general payments places this provider in the 95th percentile of 269 urology providers in Arizona.

See all urology providers in Arizona →

Medicare billing

Part B allowed, 2024

$577,645

Medicare patients

1,016

Services billed

6,975

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other urology in Mesa

Harpreet WadhwaMesa$45K
Shoaib SafiullahMesa$14K
Greggory PeiferMesa$14K
Daniel GilbertMesa$12K
Curtis DunsheeTucson$16M
Mark TysonScottsdale$4.9M
Kalpesh PatelTucson$2.3M
Susan KalotaTucson$1.2M
Mitchell HumphreysPhoenix$1.1M
Donald LammPhoenix$403K

See the full list for Arizona →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →